Cited by 13Diabetes Management and ResearchDiabetes Treatment and ManagementPancreatic function and diabetes

Nonlinear Metabolic Effect of Insulin Across the Blood Glucose Range in Patients with Type 1 Diabetes Mellitus

Open access
Chan, Alice, Heinemann, Lutz, Anderson, Stacey M., Breton, Marc D., Kovatchev, Boris P.·2010·Journal of Diabetes Science and Technology

Abstract

Background: For insulin therapy to successfully maintain blood glucose (BG) levels of patients with type 1 diabetes mellitus (T1DM) in normoglycemia, it is necessary to understand if the metabolic effect of insulin across the BG range is linear or not. Methods: We assess the ability of insulin to lower BG in patients with T1DM in hypoglycemia and hyperglycemia. The net metabolic effect of insulin, defined as the total effect resulting from both reduced endogenous glucose production and increased glucose uptake, was used to define the insulin effectiveness (IE), a measure that indicates the amplitude of glucose lowering that a unit of active insulin can achieve at a given BG level. The IE was assessed in hypoglycemia and hyperglycemia through two separate studies. In the first study, patients were subjected to a hyperinsulinemic euglycemic and hypoglycemic glucose clamp. In the second study, another group of patients were clamped at a hyperglycemic level. Results: The IE increased by 75% when BG dropped from 90 to 50 mg/dl at a steady rate of 1 mg/d1/min and decreased by 10% when BG was increased from 100 to 200 mg/d1. Conclusions: The net metabolic effect of insulin is nonlinear across the BG range and is amplified in hypoglycemia and dampened in hyperglycemia. Most importantly, the BG lowering per unit of insulin is accelerated when falling into hypoglycemia. The understanding of the accelerated risk for hypoglycemia with falling glucose levels will help the design of more robust hypoglycemia prevention and detection systems.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/193229681000400416

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Recent studies have provided new insights into nonlinearities of insulin action in the hypoglycemic range and into glucagon kinetics as it relates to response to hypoglycemia.

    “Recently new data and models have become available on hypoglycemia 5 and counterregulation. 6,7”

    From The UVA/PADOVA Type 1 Diabetes Simulator: New Features (2014) · cites this paper as [6]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Yki-Järvinen H. Glucose toxicity. Endocr Rev. 1992;13(3):415-31.

Cited by

Sorted by citations

Authors
Chan, A., Heinemann, L., Anderson, S. M., Breton, M. D., & Kovatchev, B. P.
Affiliations
  • University of Virginia Health System (US)
  • Profil Institute for Metabolic Research (DE)
Corresponding author
Chan, Alice
Venue
Journal of Diabetes Science and Technology
Published
2010-07
Volume
4
Issue
4
Pages
873-881
ISSN
1932-2968 (ISSN-L)
OpenAlex
W2131590286
Cited by
13
References
20
Citations by year
2026: 2 · 2024: 1 · 2020: 1 · 2015: 4 · 2014: 1 · 2013: 1 · 2012: 1
FWCI
0.97
Type
journal article
Language
en
Open access
Locations
  • Journal of Diabetes Science and Technology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Deutsches Krebsforschungszentrum
  • National Institutes of Health (5r01dk051562-23)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK 51562, R01DK085623)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
Keywords
type 1 diabetes, blood glucose, hypoglycemia, hyperglycemia, endogenous glucose production, glucose uptake, hyperinsulinemic-euglycemic clamp, hypoglycemic clamp, hyperglycemic clamp, hypoglycemia prevention
MeSH terms
Adult, Algorithms, Blood Glucose, Diabetes Mellitus, Type 1, Female, Glucose, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Male, Middle Aged, Glucose Clamp Technique, Treatment Outcome, Nonlinear Dynamics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review